ADMET Profiling in Drug Discovery and Development: Perspectives of In Silico, In Vitro and Integrated Approaches

Author(s): Nour El-Huda Daoud, Pobitra Borah*, Pran Kishore Deb, Katharigatta N. Venugopala*, Wafa Hourani, Muhammed Alzweiri, Sanaa K. Bardaweel, Vinod Tiwari

Journal Name: Current Drug Metabolism

Volume 22 , Issue 7 , 2021

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


In the drug discovery setting, undesirable ADMET properties of a pharmacophore with good predictive power obtained after a tedious drug discovery and development process may lead to late-stage attrition. The earlystage ADMET profiling has brought a new dimension to lead drug development. Although several high-throughput in vitro models are available for ADMET profiling, the in silico methods are gaining more importance because of their economic and faster prediction ability without the requirements of tedious and expensive laboratory resources. Nonetheless, in silico ADMET tools alone are not accurate, and therefore, ideally adopted along with in vitro and or in vivo methods in order to enhance the predictability power. This review summarizes the significance and challenges associated with the application of in silico tools as well as the possible scope of in vitro models for integration to improve the ADMET predictability power of these tools.

Keywords: In silico, in vitro, ADMET profiling, drug discovery, predictive tools, molecular descriptors, computational tools.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 14 September, 2021
Page: [503 - 522]
Pages: 20
DOI: 10.2174/1389200222666210705122913
Price: $65

Article Metrics

PDF: 71